Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Earnings History
Profitable4 years of earnings data (2021–2024) · Positive TTM net income
Loading earnings history...
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) Earnings Overview
As of June 30, 2026, Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) reported trailing twelve-month net income of $478,561, reflecting -43.7% year-over-year growth. The company earned $0.02 per diluted share over the past four quarters, with a net profit margin of 20.1%.
Looking at the long-term picture, BYAH's historical earnings data spans multiple years. The company achieved its highest annual net income of $852,042 in fiscal 2023.
Park Ha Biological Technology Co., Ltd. Ordinary Shares maintains industry-leading profitability with a gross margin of 91.8%, operating margin of 33.3%, and net margin of 20.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including CLPS (-$9M net income, -4.3% margin), CNET (-$1M net income, -38.4% margin), RETO (-$21M net income, -366.1% margin), BYAH has outperformed on profitability metrics. Compare BYAH vs CLPS →
BYAH Earnings vs Peers
Earnings metrics vs comparable public companies
BYAH Historical Earnings Data (2021–2024)
4 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $478,561 | -43.8% | $793,714 | $0.02 | 20.1% | 33.3% |
| 2023 | $852,042 | +345.4% | $1M | $0.03 | 34.6% | 48.0% |
| 2022 | $191,298 | +139.4% | $197,024 | $0.01 | 10.0% | 10.3% |
| 2021 | $-484,958 | - | $-500,976 | $-0.02 | -52.1% | -53.8% |
Download Data
Export BYAH earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
BYAH — Frequently Asked Questions
Quick answers to the most common questions about buying BYAH stock.
What is BYAH earnings per share (EPS)?
BYAH trailing twelve-month (TTM) diluted EPS is $0.02, reflecting -43.7% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2024 is available in the table on this page.
What is Park Ha Biological Technology Co., Ltd. Ordinary Shares's net income?
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) trailing twelve-month net income is $478561.00 as of 2024. Earnings declined -43.7% year-over-year. Park Ha Biological Technology Co., Ltd. Ordinary Shares has been profitable for 3 consecutive years.
Is BYAH profitable?
Yes, BYAH is profitable with a TTM net income of $478561.00 and a net profit margin of +20.1%. Park Ha Biological Technology Co., Ltd. Ordinary Shares has generated profits for 3 consecutive years.
What is BYAH's earnings growth rate?
BYAH compound annual EPS growth rates (CAGR): 1-Year: -43.7%, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2024.
What are BYAH's profit margins?
Park Ha Biological Technology Co., Ltd. Ordinary Shares net profit margin is +20.1%, operating margin is +33.3%, and gross margin is +91.8%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +38.0%.
Is BYAH growing earnings?
BYAH earnings are declining — EPS fell -43.7% year-over-year. TTM net income dropped to $478561.00. This contrasts with the 5-year CAGR of N/A.
What was BYAH's best earnings year?
Park Ha Biological Technology Co., Ltd. Ordinary Shares's highest annual net income on record is $852042.00, achieved in fiscal year 2023. Earnings history on this page spans 2021 to 2024 and includes all annual and quarterly figures.